About
Caroline Stout is a Partner at EcoR1 Capital, joining in 2014 and leading several biotechnology investments. She previously served as CIO of Panacea Acquisition Corp I and II and worked as an investment banker at Credit Suisse, and holds an economics degree from Georgetown University.
ContactΒ· self-published, not guessed
Invests in
Biotech
Board director at Affinia Therapeutics
Intro paths
β
In turn, Caroline can intro founders to Affinia Therapeutics's investors below.
Affinia Therapeutics's investors Β· 8
Atlas VentureCambridge Β· $500K β $1M checks Β· since 2025EcoR1 CapitalSan FranciscoEight Roads VenturesMumbai Β· $5M β $30M checksF-Prime CapitalCambridge Β· $3M β $10M checks Β· since 2025GV (Google Ventures)Mountain View Β· $250K β $50M checksNEA SecondaryTimonium Β· since 2025New Enterprise Associates (NEA)Menlo Park Β· $200K β $40M checksTCG CrossoverPalo Alto
Co-founders at Affinia Therapeutics
LV
Luc VandenbergheDirector
AT
Aaron Tward, M.D., Ph.D.Scientific Co-Founder
BR
Botond Roska, M.D., Ph.D.Scientific Co-Founder
LV
Luk Vandenberghe, Ph.D.Scientific Co-Founder and Adviser, and Board Member
Experience
- EcoR1 Capital, LLCPartnercurrent2020 β present
- EcoR1 Capital, LLCPrincipal2014 β 2023San Francisco Bay Area
- Attovia TherapeuticsBoard Observercurrent2025 β present
- Accent Therapeutics, Inc.Board Membercurrent2018 β presentCambridge, MA
- Notch TherapeuticsBoard Member2021 β 2025
- Affinia TherapeuticsBoard Member2021 β 2025
- Neurogene, Inc.Board Member2019 β 2024Greater New York City Area
- Panacea Acquisition Corp. IIChief Investment Officer2021 β 2023
- Affinivax Inc.Board Observer2021 β 2023
- Neogene TherapeuticsBoard Member2020 β 2023
- Panacea Acquisition Corp.Chief Investment Officer2020 β 2021
- Prevail TherapeuticsBoard Member2018 β 2019New York, NY
- Credit SuisseInvestment Banker - Healthcare2013 β 2014Greater New York City Area
- BarclaysIntern2011Wilmington, DE
- Institute for Reproductive Health at Georgetown UniversityResearch Assistant2010 β 2011Bethesda, Maryland
- Pediatrix Medical GroupNewborn Hearing Screener2008 β 2011INOVA Alexandria
Skills & more
AnalysisSpanishFinancial ModelingResearchEconomicsMergers & AcquisitionsMicrosoft OfficeFinancial AnalysisMicrosoft ExcelPowerPointValuationData Analysis
+5 more
Microsoft WordMergersStatisticsDue DiligenceFinanceLanguages Spanish
- Series 79, Limited Representative - Investment Banking β FINRA
From Caroline's professional profile.
Colleagues at EcoR1 Capital
Areesha Saif
Analyst at EcoR1 Capital
Basheer Zada
Principal at EcoR1 Capital
Caroline Cho
Executive Personal Assistant at EcoR1 Capital
Catherine McWilliams
Director of Partner Relations at EcoR1 Capital
Daniel Rodriguez
Counsel at EcoR1 Capital
Geoff Keough
Trader at EcoR1 Capital
Maddie Gehrich
Investor Relations Associate at EcoR1 Capital
Miranda Fornaro
Operations Manager at EcoR1 Capital
Frequently asked questions
- Who is Caroline Stout?
- Caroline Stout is a Partner at EcoR1 Capital, joining in 2014 and leading several biotechnology investments. She previously served as CIO of Panacea Acquisition Corp I and II and worked as an investment banker at Credit Suisse, and holds an economics degree from Georgetown University.
- Where does Caroline Stout work?
- Caroline Stout is Partner at EcoR1 Capital and Board director at Affinia Therapeutics.
- What does Caroline Stout invest in?
- Caroline Stout invests in Biotech.
- Where did Caroline Stout go to school?
- Caroline Stout studied at Georgetown University (BA, Economics (Honors)); The London School of Economics and Political Science (LSE) (Macroeconomics); Duke University (Philosophy).
Same school
Also attended Georgetown University551
Trae StephensPartner at Founders Fund and co-founder of AndurilLuciana LixandruPartner at Sequoia CapitalKatherine BoyleGeneral Partner at Andreessen Horowitz (American Dynamism)Tobi CokerDeal Partner at Felicis VenturesAna AndreescuInvestor at Index VenturesThanachat TangsriwongγΏγ€γͺγγ£γΉδ»£θ‘¨ (Thailand Office Representative) at CyberAgent Capital
+ 545 more
Also attended The London School of Economics and Political Science (LSE)1,435
Masayoshi SonFounder, Chairman & CEO of SoftBank GroupLee FixelFounder of AdditionPat GradyPartner at Sequoia CapitalNeil MehtaCo-founder & Managing Partner at GreenoaksCyriac ParisotInvestor at Index VenturesSofia DolfeInvestor at Index Ventures
+ 1,429 more
Also attended Duke University711
Fred EhrsamCo-founder and Senior Advisor at Paradigm; founder of NudgeJeremy LevinePartner at Bessemer Venture PartnersZach PerretCo-founder & CEO of Plaid; co-founder of MischiefJulie YangVice President at InvestcorpScott RaneyManaging Director at Redpoint VenturesJack Bixby LucasGeneral Partner at Lucas Venture Group
+ 705 more
Also attended The Potomac School16
Damien PettyInvestor at Morpheus VenturesAlexis KartalianSenior Coordinator, Portfolio & Community at HalcyonDavid WuInvestor at Acorn Pacific VenturesStefanie Thomas-MartinPartner at Zeal Capital PartnersFord WorthyPartner and Senior Advisor at Pappas CapitalStefanie ThomasPartner at Zeal Capital Partners
+ 10 more
Shared employers
Also worked at Neurogene, Inc.1
Also worked at Affinivax Inc.1
Also worked at Prevail Therapeutics2
Also worked at Credit Suisse975
Bill GurleyGeneral Partner Emeritus at BenchmarkMike SpeiserManaging Director at Sutter Hill VenturesNik StoronskyCo-founder & CEO of RevolutVlad YatsenkoCo-founder & CTO of RevolutRyan IsonoDeal Partner at Felicis VenturesAryo TehranianManaging Director at Mayfair Equity Partners
+ 969 more